Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
BMJ Open Science
|
January 20, 2022
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
Elda Righi, Luigia Scudeller, Margherita Chiamenti, et al.
Journal of the Pediatric Infectious Diseases Society
|
July 14, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Jennifer Le, Thomas Lodise, et al.
Trials
|
May 16, 2022
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
Nicholas A Turner, Smitha Zaharoff, Heather King, et al.
International Journal of Antimicrobial Agents
|
April 15, 2021
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli
Luigia Scudeller, Elda Righi, Margherita Chiamenti, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)
Thomas L Holland, William O'Riordan, Alison McManus, et al.
BMC Infectious Diseases
|
November 9, 2015
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection
Teresa L Kauf, Peggy McKinnon, G Ralph Corey, et al.
Clinical Therapeutics
|
November 21, 2015
Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation
Pamela A Moise, Darren L Culshaw, Annie Wong-Beringer, et al.
Pharmacotherapy
|
February 16, 2024
Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"
Lisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Pharmacotherapy
|
August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary
Lisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Pharmacotherapy
|
August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
Lisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
BMJ Open Science
|
January 20, 2022
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
Elda Righi, Luigia Scudeller, Margherita Chiamenti, et al.
Journal of the Pediatric Infectious Diseases Society
|
July 14, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Jennifer Le, Thomas Lodise, et al.
Trials
|
May 16, 2022
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
Nicholas A Turner, Smitha Zaharoff, Heather King, et al.
International Journal of Antimicrobial Agents
|
April 15, 2021
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli
Luigia Scudeller, Elda Righi, Margherita Chiamenti, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2018
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)
Thomas L Holland, William O'Riordan, Alison McManus, et al.
BMC Infectious Diseases
|
November 9, 2015
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection
Teresa L Kauf, Peggy McKinnon, G Ralph Corey, et al.
Clinical Therapeutics
|
November 21, 2015
Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation
Pamela A Moise, Darren L Culshaw, Annie Wong-Beringer, et al.
Pharmacotherapy
|
February 16, 2024
Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"
Lisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Pharmacotherapy
|
August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary
Lisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Pharmacotherapy
|
August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
Lisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Page
of 4